Loading...
Quantitative characterization of the mechanism of action and impact of a ‘proteolysis-permitting’ anti-PCSK9 antibody
A recent report described a novel mechanism of action for an anti-proprotein convertase subtilisin-kexin type 9 (PCSK9) monoclonal antibody (LY3015014, or LY), wherein the antibody has improved potency and duration of action due to the PCSK9 epitope for LY binding. Unlike other antibodies, proteolys...
Na minha lista:
| Udgivet i: | MAbs |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5297531/ https://ncbi.nlm.nih.gov/pubmed/27981884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1270490 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|